Founded in 1980, COSMED is a world-renowned manufacturer of metabolic and body composition diagnostic equipment.
COSMED product range includes:
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at www.boehringer-ingelheim.com
InBody is one of the global leader in the body composition analysis industry. InBody measures your body composition and displays it on an organized, easy-to-understand results sheet, which gives you a detailed analysis of where your fat and muscle are, where your body water levels are at. InBody can accurately show not only changes in fat mass, muscle mass and body fat percentage, but also maintenance of body shape, adequate nutritional information.
To bring you the easiest, quickest, and most precise body composition analysis for enhancing your health, See what you are made of, with InBody.
Maastricht Instruments BV is a private limited company originating from the engineering department of the Faculty of Health, Medicine & Life Sciences of the Maastricht University Medical Center+. The company is founded in 1998 and has grown into a specialized high-tech company providing high demanding customers with innovative technical solutions in the field of life sciences and medical.
Maastricht Instruments is a strategic company of Maastricht UMC+ and is providing customers all over the world with novel research equipment such as indirect calorimetry equipment, wearable healthcare solutions (devices and apps) and specialized life science tools.
Allurion Technologies is a global medical weight loss company. Launched in 2009, Allurion revolutionized the medical weight loss industry by creating the only gastric balloon that requires no endoscopy and no anesthesia for placement or removal. The Allurion Balloon is a tool at the center of a multicomponent lifestyle weight management program, designed to ensure patients’ outcome and satisfaction for sustainable weight management. The Program includes a 6-month support package from an expert multidisciplinary team, powered by customizable digital tools to help patients monitor their progress and get support from their clinic team. Now available in more than 50 countries, Allurion is proud to have helped more than 70,000 patients, with a wealth of published data demonstrating an average total body weight loss of 10 to 15% at 4 months 1-5.
The Allurion Virtual Care Suite has recently been launched to provide benefits to providers and patients beyond the Allurion Program. A suite of digital tools to power weight loss clinics, provide telehealth and remote patient monitoring for all types of weight-loss therapies including bariatric, endoscopic, behavioral and medical. The Virtual Care Suite offers tracking tools, secure end-to-end patient and population management and secure telehealth communication tools. By facilitating clinic team collaboration and helping make weight loss follow up more patient centered, Allurion aims to maximize patients ‘outcome and get closer to its mission to end obesity.
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.
Novo Nordisk is a leader in obesity care, helping advance the understanding and management of obesity as a chronic disease. Changing Obesity™ is Novo Nordisk’s long-term commitment to – together with our partners – improve the lives of people with obesity, by changing how the world sees, prevents and treats obesity.
Headquartered in Denmark, Novo Nordisk employs approximately 43,200 employees in 80 countries and markets its products in more than 170 countries.
| Contact | : Jakob Jakobsen |
| W | : www.novonordisk.com |
| P | : +45 3079 0781 |
| E | : [email protected] |
VIVUS is a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs. VIVUS is the manufacturer of Qsiva® (phentermine and topiramate modified-release) hard capsules.
Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company committed to transforming the care for patients living with rare genetic diseases of obesity. Our science is dedicated to the understanding of rare genetic diseases of obesity caused by an impaired pathway in the brain known as the melanocortin-4 receptor (MC4R) pathway. For more information about the science and our solutions, please visit our website: www.rhythmtx.com
Currax Pharmaceuticals LLC is a specialty biopharmaceutical company focused on enhancing the lives of patients worldwide by expanding access to life-changing medications that treat diseases such as obesity. Currax distributes a range of both branded and generic pharmaceutical products. For more information, please visit our website: www.curraxpharma.com
PronoKal Health Group, S.L.
Roger de Lluria, 58
08009 Barcelona –Spain-
PronoKal Group® is a multinational company specialising in medical weight loss and weight control treatments based on comprehensive programmes involving a team of healthcare professionals (doctors, dieticians-nutritionists, physical trainers and coaches).
PronoKal Group® has a wealth of experience in the weight loss sector and operates on an international level in Europe and America.
PronoKal Group® began its activities in 2004 with the launch of the PronoKal® Method in Spain. Since 2009, the expansion and internationalisation has been consolidated: PronoKal Group® is currently in more than 15 countries.
The success of our medical treatment is backed by more than 600,000 patients treated and more than 8,000 prescribing doctors who trust in the rigour and effectiveness of our methods. These figures position Pronokal Group® as a leading company in the weight management sector.
| Contact | : Ivan Benavent |
| W | : www.pronokal.com |
| P | : +34 931 833 300 / +34 687 160 069 |
| E | : [email protected] |
Mercodia is a world-leading developer, manufacturer and distributor of high quality immunoassays, notably within the area of metabolic disorders such as obesity. Through the company’s long-standing expertise in measurement quality and life cycle management, Mercodia is also an appreciated service provider. We welcome you to visit our booth for more information. https://www.mercodia.com/event/eco-2022/